Lactate dehydrogenase A (LDHA) inhibitor, AZ-33, Purity ≥98%

Synonym: 1370290-34-8; AZ 33; AZ33; 2-[[4-[4-[[3-[(2-Methyl-1,3-benzothiazol-6-yl)amino]-3-oxopropyl]amino]-4-oxobutyl]phenyl]methyl]propanedioic acid; Lactate dehydrogenase A (LDHA) inhibitor

MDL: MFCD29913759
CAS Number: 1370290-34-8
Compound CID: 56844254

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

AZ-33, soluble in DMSO, water and ethanol, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lactate dehydrogenase A (LDHA). The molecular weight of the compound is 497.56, and its molecular formula is C₂₅H₂₇N₃O₆S.

Molecular Weight

497.56

Molecular Formula

C₂₅H₂₇N₃O₆S

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 86 mg/mL (172.84 mM); Water: <1 mg/mL; Ethanol: <1 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

AZ-33 can be studied extensively for its potential therapeutic applications in the treatment of type 2 diabetes by enhancing insulin secretion in response to fatty acids.